Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
3
×
cancer immunotherapy
clinical trials
3
×
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
3
×
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
amag pharmaceuticals
astrazeneca
biotech ipos
boston top stories
bristol-myers squibb
covid-19
What
bio
roundup
acquisitions
alliance
alzheimer’s
announced
annual
assessed
attention
biotech
bristol
buy
calls
ceo
changing
collabs
color
communities
conference
covid
crispr
daniel
days
deal
drug
esmo
europe
germany
gilead
gilead’s
growing
help
hosted
hours
introduce
investment
ipo
kudos
leaves
medicines
Language
unset
Current search:
biogen
×
" texas blog main "
×
cancer
×
" clinical trials "
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More